How to read: Every bubble is one Indian hydroxychloroquine exporter. X-axis = shipment count; Y-axis = average unit price; bubble size = total revenue. Dashed lines split at the median — exporters in the top-right (Bulk Leaders) combine high volume with premium pricing.
HOW TO READ THIS REPORT
60 seconds
Scan this page — KPIs, thesis, flagship chart, top findings
5 minutes
Read every Key Takeaway line across §1–§9
30 minutes
Read sections tagged for your role ([S] or [B]) end-to-end
In depth
Drill into §10 for your country · supplier / buyer directories at end
02
PART I — OVERVIEW
About This Report
Data sources, methodology, trust signals, and what this Hydroxychloroquine report covers
KEY TAKEAWAYEvery figure in this report is grounded in real commercial hydroxychloroquine trade records. Data comes from official customs filings and public trade sources, runs through a multi-layer quality process, and lands in a clean, consistent report you can rely on.
S FOR SUPPLIERS
Every competitor benchmark, market share figure, and buyer list in this report comes from verified commercial shipments — not surveys or estimates. Use them with confidence when planning your next pitch.
B FOR BUYERS
Every supplier profile, price benchmark, and trade route in this report reflects what that supplier actually ships — real volumes, real destinations, real prices. Use them to qualify and compare Indian hydroxychloroquine suppliers.
§2.1 Reporting parameters · the scope of this 2025-Q4 Hydroxychloroquine India trade report
P
Product scope
Hydroxychloroquine
All variants merged — branded and generic formulations of hydroxychloroquine
T
Time period
2025-Q4
October, November, December 2025 — a single-quarter snapshot
S
Data sources
Official & public trade records
Government customs filings, public trade databases and licensed commercial feeds
G
Geography
India origin → global
Indian sea and air ports shipping to destination markets worldwide
C
Currency
USD (FOB)
Declared Free-on-Board value at the Indian port of loading
R
Shipments analysed
255
Every commercial hydroxychloroquine trade record in the period, aggregated and deduplicated
§2.2 Our quality process · Figure 2.1
Figure 2.1 From raw trade records to a clean report — the four quality pillars.
How to read: Raw trade data (left) flows through four quality checks — source verification, format standardisation, entity matching, and deduplication — to produce the clean, reliable data (right) behind every chart and table in this report.
§2.3 Trust signals · what you can rely on in the numbers you read
DATA COVERAGE
10M+
Pharmaceutical trade records across the full TransData Nexus platform.
COUNTRIES
150+
Origin and destination countries covered in the global pharma trade database.
Platform refresh cadence. This report is a snapshot from the same live data.
§2.4 Limitations · what the data does and does not tell you
WHAT THIS DATA DOES AND DOES NOT SAY
Prices are at the Indian port of loading (FOB), not the final delivered cost in the destination country. Freight, insurance, import duty and local margin are not included.
This is a single-quarter snapshot. Multi-quarter trends, year-over-year growth and historical comparisons are available on the full platform.
A small number of records have incomplete transport mode or destination port fields; these appear blank in the shipment register but are still counted in totals.
This report is a commercial intelligence tool, not a legal audit. For high-stakes decisions, cross-reference with the underlying trade records via the full platform.
03
PART II — MARKET STRUCTURE
Quarterly Trade Overview
Monthly trends, regional performance, and ranking shifts — 2025-Q4
KEY TAKEAWAY2025-Q4 followed a v-curve: Oct $2.6M, Nov $675.8K, Dec $875.0K. Shipment counts rose across the quarter.
S FOR SUPPLIERS
Track which months your competitors were most active, which destinations rose or fell, and whether the Nov dip hit your segment. The bump charts show rank movement — watch for rivals climbing past you.
B FOR BUYERS
Identify whether your current Indian supplier maintained steady shipments through the quarter, or whether they pulled back. Steady suppliers during dips signal reliable partnerships.
1
$2.6M
Oct USD
31 shipments
2
$675.8K
Nov USD
-73.7% MoM
3
$875.0K
Dec USD
+29.5% MoM
4
V-curve
Q4 growth shape
Oct → Nov → Dec
Fig 3.1 Nov dipped 73.7% in USD but shipment count kept climbing.
How to read: Blue bars = monthly USD. Orange line = shipment count. When bars drop but line rises, average shipment value fell. Insight: Oct opened at $2.6M, making it the strongest month by value.
How to read: The curve shows the running total across the quarter. A steeper slope means that month contributed more revenue. Insight: The curve’s steepest section reveals which month drove the most trade value.
How to read: Each coloured layer is one destination region. Layer height = USD in that month. Insight: The top region contributed the most, while the smallest region had the least volume.
How to read: Each line traces a supplier’s monthly rank. Flat = stable position; crossing = rank change. Insight: IPCA LABORATORIES LTD maintained its leading position.
04
PART II — MARKET STRUCTURE
Global Destination Map
Which countries import hydroxychloroquine from India, how much they buy, and who supplies each market
KEY TAKEAWAYUnited States absorbs 45.3% of India’s 2025-Q4 hydroxychloroquine trade ($1.9M). Beyond the top 10 destinations, 43 countries have fewer than 5 Indian suppliers each — white-space markets where new entrants face minimal competition. Africa has 14 destination countries, the widest regional diversity.
S FOR SUPPLIERS
Use the flow map and lanes table to see which destinations your competitors dominate. For small and mid-size suppliers: look beyond the leading markets — the 43 countries in the long tail have fewer than 5 Indian suppliers each and low competitive barriers.
B FOR BUYERS
Find your country on the map to see how much hydroxychloroquine India ships to your market, who the top suppliers are, and whether you’re in a concentrated or competitive corridor.
Asia
$1.2M
29.3% of trade
11 countries · 172 shipments
Europe
$709K
17.2% of trade
8 countries · 13 shipments
Americas
$1.9M
47.3% of trade
10 countries · 35 shipments
Africa
$42K
1.0% of trade
14 countries · 33 shipments
Oceania
$213K
5.2% of trade
1 countries · 2 shipments
Fig 4.1 United States is the #1 corridor ($1.9M) — 30 flow arcs from India radiate across 5 continents.
How to read: The world map shows every country colored by how much Indian hydroxychloroquine it receives (light = low, dark = high). Orange arcs radiate from India to the top 30 destinations; arc thickness = USD value. All destinations are labeled with country name + USD.
§4.1 Top 10 bilateral trade lanes (India → destination) with top Indian suppliers
#
Destination
Total USD
Ships
#1 Indian supplier
USD
#2 Indian supplier
USD
#3 Indian supplier
USD
1
United States
$1.9M
19
ZYDUS LIFESCIENCES LTD
$1.5M
V-ENSURE PHARMA TECHNOLOGIES PVT LTD
$395K
VL TRADELINK PVT LTD
$28
2
Netherlands
$449K
2
IPCA LABORATORIES LTD
$449K
—
—
—
—
3
Sri Lanka
$430K
17
ZYDUS LIFESCIENCES LTD
$260K
IPCA LABORATORIES LTD
$112K
WALLACE PHARMACEUTICALS PVT LTD
$58K
4
Vietnam
$358K
6
ZYDUS LIFESCIENCES LTD
$358K
—
—
—
—
5
Thailand
$274K
4
SUN PHARMACEUTICAL INDUSTRIES LTD
$199K
ZYDUS LIFESCIENCES LTD
$75K
—
—
6
Australia
$213K
2
IPCA LABORATORIES LTD
$213K
—
—
—
—
7
Poland
$188K
1
IPCA LABORATORIES LTD
$188K
—
—
—
—
8
Singapore
$89K
3
IPCA LABORATORIES LTD
$88K
SANITAS MEDTECH INSTITUTE PVT LTD
$688
RUCHA ENTERPRISES
$72
9
Guatemala
$40K
1
VIJAYASUDHA PHARMACEUTICALS PVT LTD
$40K
—
—
—
—
10
Malta
$36K
2
IPCA LABORATORIES LTD
$36K
—
—
—
—
Table 4.1 — Top 10 destination countries ranked by trade value, with the largest Indian suppliers for each market.
Fig 4.2 Asia leads at 29.3% of USD — but United States is the single largest market.
How to read: Column width = region USD share. Within each column, cells are stacked by country, height = share within region.
§4.2 Destination concentration
45.3%
#1 country share
United States alone
81.9%
Top 5 share
5 of 44 countries
99.0%
Top 15 share
Long tail of 29 countries = 1.0%
HHI 2452
Destination HHI
Moderately concentrated
44
Countries served
Global pharma reach from India
14
Africa countries
Widest regional diversity
Source: TransData Nexus trade data platform
05
PART III — WHO’S IN THIS MARKET
Indian Supplier Rankings & Profiles
55 Indian exporters ranked by value — profiles, portfolios, and competitive intelligence
KEY TAKEAWAYZYDUS LIFESCIENCES LTD ($2.2M, 52.5% share) and IPCA LABORATORIES LTD ($1.2M) together control 80.6% of India’s 2025-Q4 hydroxychloroquine trade. The top 5 suppliers hold 96.4%. 55 companies shipped at least once.
S FOR SUPPLIERS
Find your rank, your competitors’ ranks, and the gap in USD/share between you. The profile pages show each top supplier’s buyer portfolio, dosage mix and route map — your competitive-intelligence toolkit.
B FOR BUYERS
Find potential Indian hydroxychloroquine suppliers ranked by size, catalog breadth and destination reach. The profile pages reveal which suppliers have proven trade lanes to your region.
Fig 5.1 ZYDUS LIFESCIENCES LTD leads by $1.0M over IPCA LABORATORIES LTD — top 20 Indian exporters ranked by trade value
How to read: Each bar = one Indian supplier ranked by USD. The (#N) shows their rank by shipment count — mismatches reveal pricing strategy. Insight: MDS ENTERPRISES is #19 by value but #7 by volume.
Fig 5.2 DERRIC WOOD also leads by shipment count (82) but ranking shifts for volume-heavy players
How to read: Same suppliers re-ranked by shipment count. The (#N) shows their rank by USD value. Insight: MDS ENTERPRISES moves from #7 by volume to #19 by value — fewer but higher-value shipments.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — Archetypes & Concentration
How India’s 55 hydroxychloroquine suppliers split into strategic segments
KEY TAKEAWAY14 suppliers (25%) generate 99.7% of total trade value. The market splits into four archetypes: Market Leaders, High-Value specialists, Volume players, and a long tail.
Fig 5.3 ZYDUS LIFESCIENCES LTD and IPCA LABORATORIES LTD sit in the leaders zone — high volume AND high value.
How to read: Each bubble is one Indian supplier. X-axis = shipment count (log scale); Y-axis = total USD value (log scale); bubble size = revenue. Blue dashed lines split at the median. Market Leaders (top-right) combine high volume with high value. Premium Niche (top-left) ship fewer but higher-value consignments. Volume Players (bottom-right) compete on quantity. Long-Tail (bottom-left) are small or occasional exporters. Conclusion: the log scale reveals clear strategic clusters — use this map to identify where your company sits relative to competitors.
Fig 5.4 25% of suppliers = 99.7% of USD — classic concentration.
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 4 destinations and up to 2 importers per destination.
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 5 destinations and up to 1 importers per destination.
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 2 destinations and up to 1 importers per destination.
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 2 destinations and up to 1 importers per destination.
06
PART III — WHO’S IN THIS MARKET
Global Buyer Rankings & Intelligence
46 importers across 44 countries — who is buying Indian hydroxychloroquine and how much
KEY TAKEAWAYThe demand side is dramatically more fragmented than supply: the top 25 importers together hold only 76.2% of total USD. 89% of buyers source from a single Indian supplier — a vast pool of lock-in candidates.
S FOR SUPPLIERS
Find the importers buying from your competitors. The rankings reveal who has volume, who pays well, and who sources from multiple Indian suppliers (potential pitch targets).
B FOR BUYERS
See where you rank among global importers of Indian hydroxychloroquine. Compare your USD and shipment count against peers in your country and dosage segment.
Fig 6.1 EVERSANA LIFE SCIENCE SERVICES LLC is the #1 importer at $1.1M (27.6%) — top 25 by trade value
How to read: Same 25 importers re-ranked by shipment count.
§6.1 Sourcing diversity — how many Indian suppliers does each buyer use?
89%
Single-source
41 buyers rely on exactly 1 Indian supplier
2%
Dual-source
1 buyers use 2 Indian suppliers
2%
Multi-source (3–4)
1 buyers diversified across 3–4
7%
Broad-source (5+)
3 buyers with 5+ Indian suppliers
06
PART III — WHO’S IN THIS MARKET
Single-Source Buyers & Price Benchmark
Lock-in opportunities grouped by country + where each buyer sits on the price spectrum
KEY TAKEAWAYThese importers source hydroxychloroquine from exactly one Indian supplier. For each one, the table shows the incumbent, price, and dosage.
S FOR SUPPLIERS
This is your target list. Each row is a buyer locked into one competitor. Offer 5–10% better pricing to win the second-source slot.
B FOR BUYERS
If you see your company here, you are fully dependent on one Indian supplier. Consider qualifying a second source.
§6.2 Single-source lock-in by country
United States 4 single-source buyers
Importer
Current supplier
USD
Unit $
Dosage
EVERSANA LIFE SCIENCE …
ZYDUS LIFESCIENCES LTD
$1.1M
$0.038
Tablet
DIRECT CUSTOMER SOLUTI…
V-ENSURE PHARMA TECH…
$395K
$0.052
Tablet
NORTHSTAR DISTRIBUTION…
ZYDUS LIFESCIENCES LTD
$332K
$0.022
Tablet
KAN ONYEMA
VL TRADELINK PVT LTD
$27.538
$3.060
Tablet
Thailand 3 single-source buyers
Importer
Current supplier
USD
Unit $
Dosage
RANBAXY (THAILAND) CO …
SUN PHARMACEUTICAL I…
$199K
$3.567
Tablet
KASPA PHARMACEUTICAL (…
ZYDUS LIFESCIENCES LTD
$50K
$0.050
Tablet
KASPA PHARMACEUTICAL (…
ZYDUS LIFESCIENCES LTD
$25K
$0.025
Tablet
Vietnam 2 single-source buyers
Importer
Current supplier
USD
Unit $
Dosage
HAPHARCO J.S.C. BRANCH…
ZYDUS LIFESCIENCES LTD
$214K
$0.147
Tablet
HAPHARCO J.S.C. BRANCH
ZYDUS LIFESCIENCES LTD
$144K
$1.071
Tablet
Singapore 2 single-source buyers
Importer
Current supplier
USD
Unit $
Dosage
ZYFAS PHARMA PTE LTD
IPCA LABORATORIES LTD
$88K
$0.038
Tablet
SUCCESS INTER LINK PTE…
SANITAS MEDTECH INST…
$687.657
$9.824
Tablet
Philippines 2 single-source buyers
Importer
Current supplier
USD
Unit $
Dosage
MEDETHIX INC
BAFNA PHARMACEUTICAL…
$29K
$4.191
Tablet
WAKLU INC
NORTHERN LIFELINE
$822.482
$1.175
Tablet
§6.3 Price positioning — top 25 importers
#
Importer
Country
USD
$/ship
Tier
1
EVERSANA LIFE SCIENC…
United States
$1.1M
$142K
Premium
2
DIRECT CUSTOMER SOLU…
United States
$395K
$49K
Premium
3
NORTHSTAR DISTRIBUTI…
United States
$332K
$166K
Premium
4
SUNSHINE HEALTHCARE …
Sri Lanka
$260K
$29K
Mid
5
HAPHARCO J.S.C. BRAN…
Vietnam
$214K
$71K
Premium
6
RANBAXY (THAILAND) C…
Thailand
$199K
$199K
Premium
7
HAPHARCO J.S.C. BRANCH
Vietnam
$144K
$48K
Premium
8
EMAR PHARMA (PVT) LTD
Sri Lanka
$141K
$35K
Premium
9
ZYFAS PHARMA PTE LTD
Singapore
$88K
$88K
Premium
10
KASPA PHARMACEUTICAL…
Thailand
$50K
$50K
Premium
11
LCJ, SOCIEDAD ANONIMA
Guatemala
$40K
$40K
Premium
12
MEDETHIX INC
Philippines
$29K
$7K
Budget
13
PHARMACEUTICAL & CHE…
Zimbabwe
$29K
$14K
Budget
14
HINCUS PHARMACEUTICALS
Russia
$28K
$28K
Mid
15
KASPA PHARMACEUTICAL…
Thailand
$25K
$12K
Budget
16
EMIRATES POST COMPANY
United Arab Emirates
$11K
$130.000
Budget
17
M/S.BANERJEE & BROTH…
Nepal
$6K
$6K
Budget
18
GRODNO PHARMACIA
Belarus
$3K
$3K
Budget
19
TRUST ANESTHETIC LTD
Afghanistan
$2K
$1K
Budget
20
ACCULIFE PHARMA LTD
Kenya
$2K
$2K
Budget
21
DUOPHARM
Senegal
$1K
$1K
Budget
22
MINSKAYA PHARMACIA
Belarus
$970.080
$970.000
Budget
23
PSG EXPRESS LINK LTD
Ghana
$946.393
$946.000
Budget
24
WAKLU INC
Philippines
$822.482
$411.000
Budget
25
SUCCESS INTER LINK P…
Singapore
$687.657
$688.000
Budget
06
PART III — WHO’S IN THIS MARKET
Market Relationship Map
The top 20 × 20 supplier ↔ buyer network as a circular flow diagram
Fig 6.3 ZYDUS LIFESCIENCES LTD → EVERSANA LIFE SCIENCE SERVICES LLC is the strongest relationship.
How to read: Left semicircle = top 20 Indian suppliers; right = top 20 global buyers. Arc length = total USD; colored ribbons = individual relationships, thickness = USD value. Insight: follow the thickest ribbons to identify the dominant trading pairs.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
How Indian hydroxychloroquine prices vary by supplier, country and dosage form
KEY TAKEAWAYHydroxychloroquine prices span 59840× ($0.0003 → $15.57). The coefficient of variation is 1.64. Dosage form, not destination, is the primary price driver.
S FOR SUPPLIERS
Use the box plot to see where your product sits on the price spectrum. The tornado chart shows exactly where you sit relative to the market median.
B FOR BUYERS
Use this section to benchmark the price you pay against the market. The percentile strip tells you if your current supplier is charging you premium, mid-market or budget rates.
How to read: Each bar shows one supplier’s average unit price relative to the market median (dashed line). Red = above median (premium), green = below (budget).
COMMODITY KINGS
high volume · low unit price
Bulk API/tablet. Largest absolute USD despite lowest per-unit prices. e.g. IPCA LABORATORIES LTDSourcing: best for cost-driven procurement.
BULK LEADERS
high volume · premium price
Branded-generic leaders, above-median pricing. e.g. ZYDUS LIFESCIENCES LTDSourcing: hardest to displace; compete on relationship.
LONG-TAIL
low volume · low unit price
Spot/opportunistic players. e.g. VIJAYASUDHA PHARMACEUTICALS PVTSourcing: first to approach for new tenders.
PREMIUM NICHE
low volume · premium price
Sterile injectables and infusions. Hospital-grade. e.g. SUN PHARMACEUTICAL INDUSTRIESSourcing: expect 10× price vs tablet.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
Outlier forensics and the procurement cheat sheet — what to expect to pay by country × dosage
KEY TAKEAWAYExtreme prices are real: the highest are specialty/sterile formulations; the lowest are bulk API. The cheat sheet matrix is the take-home reference for procurement teams.
§7.2 Outlier forensics — top 10 highest and 10 lowest unit prices
↑ TOP 10 HIGHEST USD/UNIT
Date
Exporter
Country
Dosage
Qty
USD
$/unit
Why
Dec 2025
NIVIRA EXPORTS
Chile
Tablet
3
$47.83
$15.94
Specialty / small-batch
Nov 2025
M CARE
Oman
—
6
$93.43
$15.57
Specialty / small-batch
Nov 2025
M CARE
Oman
—
20
$311.45
$15.57
Specialty / small-batch
Nov 2025
ZYDUS LIFESCIENC…
Vietnam
Tablet
3K
$50K
$14.68
Specialty / small-batch
Oct 2025
ZYDUS LIFESCIENC…
Vietnam
Tablet
5K
$75K
$14.57
Specialty / small-batch
Oct 2025
ZYDUS LIFESCIENC…
Sri Lanka
Tablet
2K
$31K
$14.27
Specialty / small-batch
Oct 2025
ZYDUS LIFESCIENC…
Sri Lanka
Tablet
6K
$85K
$14.27
Specialty / small-batch
Oct 2025
ZYDUS LIFESCIENC…
Sri Lanka
Tablet
6K
$85K
$14.27
Specialty / small-batch
Oct 2025
ZYDUS LIFESCIENC…
Sri Lanka
Tablet
4K
$57K
$14.27
Specialty / small-batch
Dec 2025
BRINTON PHARMACE…
Saint Vincent and the Grenadines
—
6
$75.65
$12.61
Specialty / small-batch
↓ TOP 10 LOWEST USD/UNIT
Date
Exporter
Country
Dosage
Qty
USD
$/unit
Why
Dec 2025
INTAS PHARMACEUT…
Chile
Tablet
51K
$80.27
$0.0016
Bulk generic tablet
Dec 2025
INTAS PHARMACEUT…
Chile
Tablet
51K
$80.90
$0.0016
Bulk generic tablet
Dec 2025
INTAS PHARMACEUT…
Chile
Tablet
52K
$82.48
$0.0016
Bulk generic tablet
Dec 2025
INTAS PHARMACEUT…
Chile
Tablet
30K
$46.99
$0.0016
Bulk generic tablet
Dec 2025
NEXTWELL PHARMAC…
Somalia
Tablet
300
$0.724
$0.0024
Bulk generic tablet
Dec 2025
PREMIER ENTERPRISE
United Arab Emirates
Tablet
13
$0.052
$0.0040
Bulk generic tablet
Dec 2025
PREMIER ENTERPRISE
United Arab Emirates
Tablet
10
$0.040
$0.0040
Bulk generic tablet
Dec 2025
SHREE HARI VENTURE
United Arab Emirates
Tablet
20
$0.082
$0.0041
Bulk generic tablet
Dec 2025
AASHIRWAD PHARMA…
Dominica
Tablet
10
$0.044
$0.0044
Bulk generic tablet
Dec 2025
DEEP IMPEX
United Arab Emirates
Tablet
3
$0.014
$0.0046
Bulk generic tablet
§7.3 Procurement cheat sheet — median USD/unit by country × dosage
Fig 7.2 Median unit price by country × dosage form — darker cells = higher prices.
How to read: Each cell shows the median price per unit for that country-dosage combination. Dark blue = expensive, light = cheap. Blank cells = no shipments in that combination.
NEGOTIATION RANGE
Use each cell value as the anchor price. Typical dynamics:
Dosage form is the #1 price driver, not destination
Light cells = easy-entry markets for small suppliers
Dark cells = premium markets requiring regulatory investment
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Which Indian ports ship hydroxychloroquine, which global ports receive it, and which corridors are high-value vs bulk
KEY TAKEAWAYHydroxychloroquine leaves India through 10+ ports. The top 5 (NHAVA SHEVA SEA (JNPT), MUNDRA SEA, MUMBAI AIR (SAHAR)) handle 97.7% of total USD. SEA moves 19% of shipments.
S FOR SUPPLIERS
Use the dumbbell to classify your port as high-value hub or bulk workhorse. Note the short-sea routes — Bangladesh, Sri Lanka, Myanmar and East Africa are the easiest logistics corridors for first-time exporters.
B FOR BUYERS
Use the destination port ranking to find which Indian ports serve your market. The lead-time estimates tell you what transit time to expect.
Fig 8.1 NHAVA SHEVA SEA (JNPT) handles $1.6M — top 10 Indian origin ports by trade value.
How to read: Each bar = one destination port worldwide. Bar length = USD value received from India.
§8.1 Reference transit times for key India → global corridors
Route
Mode
Transit time
Notes
NHAVA SHEVA SEA (JNPT) → US East Coast
Sea
22–28 days
Via Suez; 2–3 transshipments typical
NHAVA SHEVA SEA (JNPT) → Lagos (Nigeria)
Sea
18–24 days
Direct liner service available
MUMBAI AIR (SAHAR) → New York JFK
Air
3–5 days
Direct cargo; cold-chain available
MUNDRA SEA → Rotterdam
Sea
20–26 days
Via Suez; Hamburg also served
HYDERABAD AIR → London Heathrow
Air
2–4 days
Pharma-grade cargo corridor
CHENNAI SEA → Chittagong (Bangladesh)
Sea
7–12 days
Short-sea route; high frequency
RAXAUL → Birgunj (Nepal)
Road
1–2 days
Land border crossing
NHAVA SHEVA SEA (JNPT) → Mombasa (Kenya)
Sea
14–20 days
Direct or via Colombo hub
Table 8.1 — Reference times based on standard shipping corridors. Air = 2–5 days; sea = 7–28 days; road = 1–2 days. Add 3–7 days for customs clearance at destination.
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Trade corridors — origin port to mode of transport to destination region
KEY TAKEAWAYSEA dominates at 19% of shipments. The alluvial traces every dollar from Indian origin port through transport mode to destination region.
SEA
$3.1M
74.2% of USD · 18.8% of ships
AIR
$855K
20.8% of USD · 79.2% of ships
ICD
$201K
4.9% of USD · 1.6% of ships
ROAD
$6K
0.1% of USD · 0.4% of ships
Fig 8.3 The dominant corridor is MUNDRA SEA → Sea → N. America ($1.5M).
How to read: Left = Indian origin ports. Middle = transport mode. Right = destination region. Ribbon thickness = USD value; color = mode. Follow the thickest ribbons to find the highest-value corridors.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market concentration, supply-chain risk, and the dependency patterns that signal where to act
KEY TAKEAWAYVietnam is the most concentrated destination (HHI 10000, 1 suppliers). Kenya is the most competitive (HHI 4476).
S FOR SUPPLIERS
The HHI barbell shows where competitors have locked up a market (concentrated = poaching opportunity) vs where you must compete on quality (fragmented). The slope chart reveals who is gaining ground.
B FOR BUYERS
The HHI barbell tells you whether your country has enough supplier options. If concentrated (red zone), you have fewer alternatives.
Fig 9.1 Vietnam (HHI 10,000) is the most concentrated — Kenya (HHI 4,476) is the most competitive.
What is HHI? The Herfindahl-Hirschman Index measures how concentrated a market is among its suppliers. It ranges from 0 to 10,000. Below 1,500 (green zone) = many suppliers compete openly — healthy, competitive market with low risk. 1,500–2,500 (yellow zone) = a few suppliers hold significant share — moderate concentration. Above 2,500 (red zone) = one or two suppliers dominate the market — high risk for buyers who may lose supply, and hard to break into for new suppliers. Conclusion: 20 of 20 destination markets are concentrated (red zone). 0 are competitive (green zone). Buyers in red-zone markets should urgently qualify a second Indian supplier to reduce dependency risk.
§9.1 Single-source dependencies
Buyer
Country
Sole supplier
USD
Ships
Risk
EVERSANA LIFE SCIENC…
United States
ZYDUS LIFESCIENC…
$1.1M
8
CRITICAL
DIRECT CUSTOMER SOLU…
United States
V-ENSURE PHARMA …
$395K
8
HIGH
NORTHSTAR DISTRIBUTI…
United States
ZYDUS LIFESCIENC…
$332K
2
HIGH
SUNSHINE HEALTHCARE …
Sri Lanka
ZYDUS LIFESCIENC…
$260K
9
HIGH
HAPHARCO J.S.C. BRAN…
Vietnam
ZYDUS LIFESCIENC…
$214K
3
HIGH
RANBAXY (THAILAND) C…
Thailand
SUN PHARMACEUTIC…
$199K
1
HIGH
HAPHARCO J.S.C. BRANCH
Vietnam
ZYDUS LIFESCIENC…
$144K
3
HIGH
ZYFAS PHARMA PTE LTD
Singapore
IPCA LABORATORIE…
$88K
1
MEDIUM
Conclusion: 41 buyers depend on exactly one Indian supplier, representing $3.0M in trade. 1 are rated CRITICAL — if their sole supplier fails, they have no backup. For suppliers: each row is a competitor’s locked-in customer you can target.
§9.2 Multi-source resilience
Buyer
Country
Suppliers
USD
Dominant
Resilience
EMIRATES POST COMPANY
United Arab Emirates
4
$11K
DERRIC WOOD
MEDIUM
EMIRATES POST GROUP
United Arab Emirates
7
$353
DEEP IMPEX
HIGH
Conclusion: 1 of these buyers have HIGH resilience (3+ active suppliers). These are the hardest accounts to win but safest partners for long-term contracts.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market entry playbook and risk landscape by destination country
KEY TAKEAWAY15 target markets with specific entry approaches. Large suppliers: focus on regulated Tier 1 markets. Small/mid-size: start with Tier 2–3 (low barrier, growing demand).
§9.3 Sourcing recommendations · Table 9.1
Country
Tier
Lead
Price
Risk
Entry approach
United States
Tier 3 (emerging)
3–5 days (air)
$0.10–$1/unit
LOW
First-mover advantage
Netherlands
Tier 3 (emerging)
14–28 days (sea)
$0.01–$0.10/unit
LOW
First-mover advantage
Sri Lanka
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
Vietnam
Tier 3 (emerging)
14–28 days (sea)
$1–$10/unit
LOW
First-mover advantage
Thailand
Tier 3 (emerging)
14–28 days (sea)
$0.10–$1/unit
LOW
First-mover advantage
Australia
Tier 3 (emerging)
14–28 days (sea)
$0.01–$0.10/unit
LOW
First-mover advantage
Poland
Tier 3 (emerging)
14–28 days (sea)
$0.01–$0.10/unit
LOW
First-mover advantage
Singapore
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
Guatemala
Tier 3 (emerging)
3–5 days (air)
$0.10–$1/unit
LOW
First-mover advantage
Malta
Tier 3 (emerging)
3–5 days (air)
$0.10–$1/unit
LOW
First-mover advantage
Philippines
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
Honduras
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
Zimbabwe
Tier 3 (emerging)
3–5 days (air)
$0.10–$1/unit
LOW
First-mover advantage
Russia
Tier 3 (emerging)
3–5 days (air)
$0.01–$0.10/unit
LOW
First-mover advantage
United Arab Emirates
Tier 2 (competitive)
3–5 days (air)
$1–$10/unit
MEDIUM
Price + relationship
For suppliers: Tier 1 markets (US, UK, France) require regulatory investment but offer premium pricing. Tier 3 markets (emerging) have low barriers — ideal for first-time exporters. For buyers: Use the price band and lead time to benchmark your current supplier’s terms.
Fig 9.2 0 markets in the Growth Opportunity zone (competitive + growing). 13 in Fragile Dependency (concentrated + shrinking).
How to read: Each bubble = one destination. X-axis = HHI (concentration). Y-axis = growth %. Bubble size = USD. Green zone (top-left) = Growth Opportunity — competitive markets that are growing, best for new entrants. Red zone (bottom-right) = Fragile Dependency — concentrated + shrinking, high supply-chain risk. Conclusion: Key markets are the top growth opportunities.
09
PART V — ACTION
Action Plan & Easy-Entry Markets
12 prioritised actions + 15 low-competition destination countries for small & mid-size suppliers
KEY TAKEAWAYQuick Wins: execute this quarter. Big Bets: plan for next 6–12 months. Plus 15 countries with ≤5 Indian suppliers — the best entry points for SMEs.
S
FOR SUPPLIERS
ID
Action
Timing
Impact
A1
Pitch top single-source buyer in United States
This Q
HIGH
A2
Offer alternative to EMIRATES POST
This Q
HIGH
A3
Audit Vietnam lock-ins (HHI 10000)
This Q
MED
A5
Enter United States (3 suppliers)
This Q
HIGH
A6
Enter Netherlands (1 suppliers)
This Q
MED
A8
Build Netherlands distribution
6–12m
HIGH
A9
Bundle injection/infusion catalog for premium markets
6–12m
MED
B
FOR BUYERS
ID
Action
Timing
Impact
A4
Monitor rising exporters (climbers)
This Q
MED
A7
Register for United States tenders
6–12m
HIGH
A10
Track quarterly HHI shifts across key destinations
This Q
LOW
A11
Map competitor buyer portfolios quarterly
This Q
MED
A12
Qualify second source for single-source buyers
This Q
MED
§9.4 Easy-entry markets — 15 countries with ≤5 Indian suppliers
#
Country
Region
Suppliers
Q4 USD
Growth
Barrier
Why this is easy
1
United States
Other
3
$1.9M
-69%
LOW
Low competition (3 suppliers), accessible market
2
Netherlands
Other
1
$449K
-100%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
3
Sri Lanka
Asia
3
$430K
-56.6%
LOW
Low competition (3 suppliers), accessible market
4
Vietnam
Asia
1
$358K
-93.5%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
5
Thailand
Asia
2
$274K
-99.9%
LOW
Only 2 Indian suppliers — near-monopoly, easy second-source entry
6
Australia
Other
1
$213K
-48.3%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
7
Poland
Other
1
$188K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
8
Singapore
Asia
3
$89K
0%
LOW
Low competition (3 suppliers), accessible market
9
Guatemala
Other
1
$40K
-100%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
10
Malta
Other
1
$36K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
11
Philippines
Asia
3
$32K
-91.5%
LOW
Low competition (3 suppliers), accessible market
12
Honduras
Other
1
$32K
-100%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
13
Zimbabwe
Africa
1
$29K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
14
Russia
Other
1
$28K
-100%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
15
Venezuela
Other
1
$10K
-100%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
This report covers 255 2025-Q4 Hydroxychloroquine shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/hydroxychloroquine
10
PART VI — EVIDENCE REGISTER
Comprehensive Shipment Records by Region
Authoritative source behind all analytics in this report — every shipment appears exactly once
KEY TAKEAWAYThis section contains every one of the 255 2025-Q4 hydroxychloroquine shipments, organised by Region → Exporter → Shipment rows. No row is duplicated.
S FOR SUPPLIERS
Jump to any destination country to see exactly who your competitors ship to, what they charge, through which port, and how often.
B FOR BUYERS
Jump to your country to see every Indian hydroxychloroquine shipment that arrived in 2025-Q4: supplier, price, dosage, port.
§10.1 Global totals
SHIPMENTS
255
across all regions
TOTAL USD
$4.12M
2025-Q4 FOB value
UNITS
79.4M
tablets, capsules, etc.
SUPPLIERS
55
Indian exporters
BUYERS
46
global importers
COUNTRIES
44
destinations
§10.2 Regional breakdown
Africa
$42K
1.0%
14 ctry · 33 ships
Asia
$1.21M
29.3%
11 ctry · 172 ships
Europe
$709K
17.2%
8 ctry · 13 ships
Americas
$1.95M
47.3%
10 ctry · 35 ships
Oceania
$213K
5.2%
1 ctry · 2 ships
§10.3 Key insights from the data
🌍
Africa is the largest region at $42K (1.0%), spanning 14 countries.
🏢
55 Indian suppliers shipped to 46 buyers across 44 countries — average shipment value $16K.
📄
Top 0 markets: .
🔍
Every row below is real customs data — date, importer, dosage, brand, quantity, unit price, total USD, origin port, destination port, and transport mode.
All 44 global hydroxychloroquine importers — complete list ranked by USD
KEY TAKEAWAYThis directory lists every company that imported Indian hydroxychloroquine in 2025-Q4.
S FOR SUPPLIERS
Search for potential customers by country and dosage form.
B FOR BUYERS
Find your company and see which Indian supplier serves you.
#
Buyer
Country
Ships
USD
Primary supplier
Dosage forms
1
EVERSANA LIFE SCIENCE SERVICES LLC
United States
8
$1.14M
ZYDUS LIFESCIENCES LTD
Tablet
2
DIRECT CUSTOMER SOLUTIONS LLC
United States
8
$395K
V-ENSURE PHARMA TECH…
Tablet
3
NORTHSTAR DISTRIBUTION CENTER
United States
2
$332K
ZYDUS LIFESCIENCES LTD
Tablet
4
SUNSHINE HEALTHCARE LANKA LTD
Sri Lanka
9
$260K
ZYDUS LIFESCIENCES LTD
Tablet
5
HAPHARCO J.S.C. BRANCH.27B NGUYEN D
Vietnam
3
$214K
ZYDUS LIFESCIENCES LTD
Tablet
6
RANBAXY (THAILAND) CO LTD
Thailand
1
$199K
SUN PHARMACEUTICAL I…
Tablet
7
HAPHARCO J.S.C. BRANCH
Vietnam
3
$144K
ZYDUS LIFESCIENCES LTD
Tablet
8
EMAR PHARMA (PVT) LTD
Sri Lanka
4
$141K
IPCA LABORATORIES LTD
Tablet
9
ZYFAS PHARMA PTE LTD
Singapore
1
$88K
IPCA LABORATORIES LTD
Tablet
10
KASPA PHARMACEUTICAL (THAILAND)CO
Thailand
1
$50K
ZYDUS LIFESCIENCES LTD
Tablet
11
LCJ, SOCIEDAD ANONIMA
Guatemala
1
$40K
VIJAYASUDHA PHARMACE…
Tablet
12
MEDETHIX INC
Philippines
4
$29K
BAFNA PHARMACEUTICAL…
Tablet
13
PHARMACEUTICAL & CHEMICAL
Zimbabwe
2
$29K
IPCA LABORATORIES LTD
Tablet
14
HINCUS PHARMACEUTICALS
Russia
1
$28K
IPCA LABORATORIES LTD
Tablet
15
KASPA PHARMACEUTICAL (THAILAND)
Thailand
2
$25K
ZYDUS LIFESCIENCES LTD
Tablet
16
EMIRATES POST COMPANY
United Arab Emirates
82
$11K
DERRIC WOOD
Tablet
17
M/S.BANERJEE & BROTHERS
Nepal
1
$6K
IPCA LABORATORIES LTD
Tablet
18
GRODNO PHARMACIA
Belarus
1
$3K
IPCA LABORATORIES LTD
Tablet
19
TRUST ANESTHETIC LTD
Afghanistan
2
$2K
S PHARMA
Tablet
20
ACCULIFE PHARMA LTD
Kenya
1
$2K
CENTURION LABORATORI…
Tablet
21
DUOPHARM
Senegal
1
$1K
SAKAR HEALTHCARE LTD
Tablet
22
MINSKAYA PHARMACIA
Belarus
1
$970.08
IPCA LABORATORIES LTD
Tablet
23
PSG EXPRESS LINK LTD
Ghana
1
$946.39
STALLION LABORATORIE…
Tablet
24
WAKLU INC
Philippines
2
$822.48
NORTHERN LIFELINE
Tablet
25
SUCCESS INTER LINK PTE LTD
Singapore
1
$687.66
SANITAS MEDTECH INST…
Tablet
26
IPCA LABORATORIES UK LTD
United Kingdom
3
$598.94
IPCA LABORATORIES LTD
Tablet
27
COCIETE BIKA MULTI ACTIVITIES
Chad
1
$369.37
BAKER & DAVIS PVT LTD
Tablet
28
EMIRATES POST GROUP
United Arab Emirates
29
$353.16
DEEP IMPEX
Tablet
29
GOOD HEALTH (PTY) LTD
Seychelles
1
$327.41
JYOTI IMPEX
30
CYERDITTRADING CO LTD
Kenya
1
$313.98
AFRO LIFESCIENCE
Tablet
31
GALINOS FARM DOO ILINDEN
North Macedonia
1
$297.83
OCEAN PHARMACEUTICAL
Tablet
32
LUSAKA PHARMA CHEM SUPPLIES LTD
Zambia
2
$283.86
MEDICOS LIFESCIENCES
Strip, Tablet
33
LIFELINE PHARMACEUTICALS OF
Lesotho
2
$164.81
NUMED PHARMA DISTRIB…
Tablet
34
LLC SHIFOI SONI
Tajikistan
1
$157.83
M.K.PHARMA
Tablet
35
MADAU KUAAC AYAI KON
Sudan
1
$144.73
AFRO LIFESCIENCE
Tablet
36
LIFE LINE PHARMACEUTICALS OF WHOLES
Lesotho
1
$112.26
NUMED PHARMA DISTRIB…
Tablet
37
LUSAKA MEDICAMP LTD
Zambia
2
$111.27
MEDICOS LIFESCIENCES
Tablet
38
MANUEL DE JESUS MOLINA PADILLA
Cuba
1
$54.00
GLOBALSTAR COMPANY
Tablet
39
FARMACIA ETICA SPA
Chile
1
$47.83
NIVIRA EXPORTS
Tablet
40
KAN ONYEMA
United States
1
$27.54
VL TRADELINK PVT LTD
Tablet
41
VITAL RANK SDN BHD
Malaysia
1
$26.44
BABA AGENCIES
Tablet
42
REGENCY EXIM TRADE LTD
Mauritius
1
$17.62
SAVA HEALTHCARE LTD
Tablet
43
NIMOZ PHARMACEUTICALS PLC
Ethiopia
1
$11.39
SKYNOX OVERSEAS PVT …
44
FIRST CHOICE PHARMACY
Dominica
1
$0.044
AASHIRWAD PHARMA INT…
Tablet
This report covers 255 2025-Q4 Hydroxychloroquine shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/hydroxychloroquine
Talk to our trade analyst
Need a custom hydroxychloroquine report or a deeper dive into any market? Our team is ready.